AFAIK Dispatch #11 Alzheimer’s Families for Action, Innovation and Knowledge I would like to believe that I’ve been wrong. There are positive clinical results from another drug, donanemab, joining Leqembi (which has already had expedited FDA approval.) Results below. My ongoing concerns are the pressure on the FDA to release something, anything, that might halt or reverse cognitive decline —…

Unlocking the Seventh Circuit of Consciousness in Theory and Practice Don Dulchinos Neurosphere.org donaldpeterdulchinos.medium.com INTRODUCTION/RECAP In a previous article in New Trajectories, I reviewed the Leary/Wilson writings on Circuit 7, and specifically in Info-Psychology: Circuits 7 and 8 seemed no more specific than they had been 10 years earlier, at least as I read it then. But wait! — “the…

AFAIK Dispatch #10 Alzheimer’s Families for Action, Innovation and Knowledge Feature Note — Bredeson Protocol When communicating about AFAIK and its concerns, I occasionally get responses from holistic health devotees about the Bredeson Protocol. While I am actually sympathetic to holistic medicine, particularly in areas where traditional medicine has been…

My article on trends in the fast developing area of EV charging, from Electrical Engineering Magazine, February 2023.

AFAIK Dispatch #9 Alzheimer’s Families for Action, Innovation and Knowledge Cognito Therapeutics just announced a $73 million funding round to support clinical trials of their GammaSense neuromodulation treatment. Early studies showed significant slowing of cognitive decline (though not reversal). …

Quantum Consciousness Dispatch #2 INTRODUCTION Among many theories of developmental psychology (Maslow, Graves et al), the creation of a similar theory by Timothy Leary was mostly lost in the noise of his phases as a guru in the 60’s, and then a criminal fugitive in the early 70’s. But Leary…

The Non-Pharma Landscape — Big Clinical Players AFAIK Dispatch #8 Alzheimer’s Families for Action, Innovation and Knowledge Introduction I have taken the position in this AFAIK series that pharmacological treatments for Alzheimer’s Disease and other forms of cognitive decline see an overwhelming majority of funding and attention relative to neurostimulation approaches. …

Epigenetics Dispatch #2 — Don Dulchinos — neurosphere.org Introduction In an earlier article, I tried to bring developmental psychology theories up to date by proposing a biological mechanism driving movement across levels of existence (Clare Graves) or circuits (Tim Leary and Robert Anton Wilson); namely, the development of the science…

AFAIK Dispatch #7 Alzheimer’s Families for Action, Innovation and Knowledge My mother-in-law, Frances Bigda, passed away recently, from complications of Alzheimer’s Disease and the flu. She was very intelligent, cultivated an active physical and intellectual life, and had a life-long teaching career culminating in becoming a high-school principal. She was…